These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6821557)

  • 1. Cytostatic effects of activated macrophages on tumor target cells: inhibition of cytotoxic action of ARA-C.
    Krahenbuhl JL; Remington JS
    J Immunopharmacol; 1980; 2(3):325-48. PubMed ID: 6821557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of growth and metastases of lung carcinoma in C57BL/6 mice by Corynebacterium parvum and its antitumor mechanism].
    Xiao Y; Lu Y; Zhang J; Cao J; Huang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):318-21. PubMed ID: 2093073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
    Campbell MW; Sholley MM; Miller GA
    Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin-activated macrophages as tumor growth inhibitors.
    Haskill JS
    Cancer Res; 1981 Oct; 41(10):3852-6. PubMed ID: 7284993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Corynebacterium parvum on Escherichia coli infection in mice.
    Yoshikai Y; Miake S; Mituyama M; Nomoto K
    J Gen Microbiol; 1982 Dec; 128(12):2857-63. PubMed ID: 6763935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
    Lichtenstein A
    Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide.
    Fisher B; Rubin H; Wolmark N
    J Natl Cancer Inst; 1976 Aug; 57(2):317-22. PubMed ID: 1003514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.
    Ryning FW; Krahenbuhl JL; Remington JS
    Immunology; 1981 Apr; 42(4):513-9. PubMed ID: 7239556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants.
    Hashimoto S; Nomoto K; Nagaoka M; Yokokura T
    Cancer Immunol Immunother; 1987; 24(1):1-7. PubMed ID: 3102062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of tumour cells to elicit the respiratory burst in cytotoxic, activated macrophages.
    Bryant SM; Hill HR
    Immunology; 1982 Mar; 45(3):577-85. PubMed ID: 6277777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophages.
    Berd D; Mastrangelo MJ
    Br J Cancer; 1981 Dec; 44(6):819-27. PubMed ID: 7326193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for granulocyte-mediated macrophage activation after C. parvum immunization.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 75(2):367-77. PubMed ID: 6831566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence of asbestos-activated macrophages.
    Donaldson K; Cullen RT
    Br J Exp Pathol; 1984 Feb; 65(1):81-90. PubMed ID: 6320857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse effect of pregnancy on macrophage activation.
    Luft BJ; Remington JS
    Cell Immunol; 1984 Apr; 85(1):94-9. PubMed ID: 6713543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of tumor cytolytic/cytostatic factor(s) by in vitro cisplatin treated macrophages: enhanced tumoricidal activity by increase in osmotic fragility of target cells.
    Singh SM; Sodhi A; Pai K; Geetha B
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):67-73. PubMed ID: 1804054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.